Pursuant to regulation 32(6) of the SEBI (LODR) Regulations, 2015 and regulation 41 of SEBI (ICDR) Regulations, 2018 enclosing herewith monitoring agency report dated May 15, 2026 issued by CRISIL Ratings Limited for the quarter ended March 31, 2026 in respect of utilization of proceeds of the IPO of the Company.
JNKINDIA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
JNK India Limited filed its quarterly monitoring agency report for the quarter ending March 31, 2026, submitted by CRISIL Ratings Limited. The report tracks utilization of IPO proceeds raised in April 2024 (issue size Rs 3,000 million). As of Q4 FY2026, the company has utilized Rs 2,814.34 million out of revised net proceeds of Rs 2,816.99 million. Working capital requirements (Rs 2,646.50 million budgeted) saw Rs 2,643.85 million deployed, with Rs 2.65 million remaining unutilized due to a minor delay—expected to be completed in FY2027. General corporate purposes (Rs 170.49 million) have been fully utilized. The net proceeds were slightly revised downward by Rs 4.85 million due to higher-than-estimated issue expenses. No material deviations or unfavorable events were reported by the monitoring agency.
This is a routine regulatory filing with no concerns. The near-complete deployment of IPO funds (99.9%) indicates the company is on track with its stated objectives. The minor Rs 2.65 million delay in working capital utilization is immaterial and within permissible limits as per the prospectus terms. Shareholders can view this as a positive development showing orderly deployment of IPO proceeds.